STOCK TITAN

Maximus Stock Price, News & Analysis

MMS NYSE

Welcome to our dedicated page for Maximus news (Ticker: MMS), a resource for investors and traders seeking the latest updates and insights on Maximus stock.

Maximus, Inc. (NYSE: MMS) is frequently in the news as a strategic partner to government and a provider of tech-enabled government services. Company announcements focus on contracts with U.S. federal agencies, U.S. states, and selected international programs, as well as updates on financial performance, capital allocation, and technology capabilities. This news page aggregates those disclosures so readers can follow how Maximus’ government-focused business evolves over time.

News about Maximus often highlights new or renewed contracts and program awards. Recent examples include agreements to support state-based health insurance marketplaces, such as enrollment and premium billing services for the Massachusetts Health Connector, and a renewed contract with Pennsylvania’s Department of Human Services to administer the Pennsylvania Enrollment Assistance Program, including expanded support for Children’s Health Insurance Program recipients. Federal sector news has featured a Joint Cyber Command & Control Readiness contract with the U.S. Air Force, covering engineering analysis, software modification, maintenance, and enhancement of cyber command and control systems.

Investors and observers can also find earnings releases and financial updates here. Maximus regularly reports segment performance for U.S. Federal Services, U.S. Services, and Outside the U.S., along with commentary on clinical program volumes, technology initiatives, margins, and free cash flow. The company also issues announcements on dividends and stock purchase program authorizations, reflecting its capital deployment approach.

Technology and cybersecurity developments are another recurring theme. Maximus has reported achieving Cybersecurity Maturity Model Certification (CMMC) Level 2, underscoring its ability to meet U.S. Department of Defense cybersecurity standards. Other news covers digital solutions such as member portals, multichannel engagement tools, and AI-based training for contact center staff. For anyone tracking MMS news, this page offers a centralized view of contract wins, program milestones, financial results, and technology-related updates tied to the company’s role in public sector service delivery.

Rhea-AI Summary

Maximus (NYSE: MMS) reported strong Q1 FY2025 results with revenue increasing 5.7% to $1.40 billion, driven by 6.3% organic growth primarily from U.S. Federal Services. Diluted EPS was $0.69 and adjusted diluted EPS reached $1.61, compared to $1.04 and $1.34 in the prior year.

The company raised its FY2025 guidance, expecting adjusted EBITDA margin of 11.2% and adjusted diluted EPS between $5.90-$6.20. Revenue guidance was adjusted to $5.2-$5.35 billion following recent divestitures. During Q1, Maximus purchased 3.1 million shares for $237 million, with additional 0.7 million shares bought for $52.9 million after quarter-end.

U.S. Federal Services revenue grew 15.3% to $780.7 million, while U.S. Services revenue decreased 7.7% to $452.3 million. Outside U.S. Segment showed 6.0% growth to $169.8 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.69%
Tags
-
Rhea-AI Summary

Maximus (NYSE: MMS), a government services provider, has announced it will release its financial results for Q1 fiscal 2025, covering the period ended December 31, 2024. The company will publish its financial results via press release at 6:30 a.m. ET on Thursday, February 6, 2025.

A conference call will follow at 9:00 a.m. ET on the same day. The call will be accessible to the public through webcast and phone, with domestic callers using 877.407.8289 and international callers using +1.201.689.8341. A recording of the webcast will be made available on investor.maximus.com for those unable to attend the live call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
conferences earnings
-
Rhea-AI Summary

Maximus (NYSE: MMS) announced that its subsidiary, Veterans Evaluation Services (VES), has been awarded new contracts by the Veterans Benefit Administration (VBA) to continue providing Medical Disability Exam (MDE) services for domestic Regions 1 through 4. The contracts, effective January 1, 2025, span the continental U.S. and include a one-year base with a single option year, addressing current and anticipated production volumes. These contracts follow a surge in demand that led to the early recompete of Regions 1 through 4. VES has continuously held MDE contracts since 2008 and also services Region 6 Pre-Discharge and Region 7 OCONUS contracts. The MDE program is important for the VBA's Compensation and Pension program, which determines veterans' disability benefits. Maximus' CEO Bruce Caswell and VES Managing Director Rob Nydam expressed pride in their team's dedication and commitment to enhancing veteran services. The VBA has seen a significant increase in disability claims since the 2022 PACT Act, further highlighting the importance of these contracts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
none
Rhea-AI Summary

Maximus (NYSE: MMS), a leading provider of government services worldwide, has announced that its Board of Directors approved a quarterly cash dividend of $0.30 per share. The dividend will be payable on February 28, 2025, to shareholders of record on February 15, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
dividends
-
Rhea-AI Summary

Maximus (NYSE:MMS) has announced a $200 million increase to its stock purchase program. The previous authorization of $200 million, announced in June 2024, had $171.4 million available as of September 30, 2024, but recent purchases have exhausted this capacity.

The company will buy shares at market prices, through 10b5-1 plans, or privately negotiated transactions, with the timing and amount of purchases based on market conditions and corporate needs. This program has no expiration date and can be modified or discontinued at any time.

Bruce Caswell, President and CEO, emphasized that this move aligns with their strategy to maximize shareholder value and reflects confidence in their future as a partner to government.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
none
-
Rhea-AI Summary

Maximus (NYSE: MMS), a leading government services provider, announced the completion of its divestiture of operations in Australia and South Korea, part of its Outside the U.S. segment. The purchaser, Angus Knight, operates in seven countries, focusing on employment, education, health, and community services. Maximus has been in Australia since 2002 and South Korea since 2020, with over 1,200 employees transitioning to Angus Knight. This move follows prior divestitures in Sweden, Italy, Singapore, and Canada.

According to CEO Bruce Caswell, this transaction aligns with Maximus' strategy to optimize its Outside the U.S. portfolio. The combined annual revenue run-rate for the divested entities was around $120 million, with an estimated $100 million impact on fiscal year 2025 revenue guidance. The transaction is expected to be slightly accretive to fiscal year 2025 adjusted EBITDA margin and adjusted diluted EPS guidance, excluding non-cash foreign exchange losses. The margin outlook for the Outside the U.S. segment is projected to improve to between 3% and 5%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
none
Rhea-AI Summary

Maximus (NYSE: MMS) announces that the U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS) has withdrawn their early re-procurement of the Contact Center Operations (CCO) contract for 1-800-MEDICARE and Federal Marketplace services. This decision means Maximus will continue its current contract, which has available option periods until 2031, without having to recompete for the same scope of work. The company currently provides support to more than 75 million eligible Americans who rely on Medicare and the Federal Marketplace.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.54%
Tags
none
-
Rhea-AI Summary

Maximus (NYSE: MMS) announced that the U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services (CMS) has cancelled their Contact Center Operations (CCO) re-procurement solicitation. This cancellation affects the 1-800-MEDICARE and Federal Marketplace operations, which Maximus currently manages. The company will continue providing these services through existing contract option periods available until 2031. The program supports over 75 million eligible Americans who depend on Medicare and the Federal Marketplace.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.54%
Tags
none
-
Rhea-AI Summary

Maximus (NYSE: MMS) reported strong financial results for fiscal year 2024, with revenue increasing 8.2% to $5.31 billion. Full year diluted earnings per share reached $4.99, with adjusted EPS at $6.11. The company demonstrated solid organic growth of 8.8%, driven by higher volumes in U.S. segments. Operating margin improved to 9.2%, with adjusted EBITDA margin at 11.6%. Cash flows from operations totaled $515 million, with free cash flow of $401 million. The company announced fiscal 2025 guidance with revenue expected between $5.275-$5.425 billion and adjusted diluted EPS of $5.70-$6.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.92%
Tags
Rhea-AI Summary

Maximus showcases its commitment to Veterans through its VETS Employee Resource Group (ERG), featuring interviews with key members. The ERG supports Veterans' transition to civilian careers and military families. The company has received multiple recognitions in 2024, including listings on the Military Times Best for Vets: Employers and Military.com Best Military Spouse Employer lists, along with several Military Friendly® awards. The podcast 'ERGs Unplugged' highlights members' experiences, including Keith Egelston (retired Air Force Veteran and ERG President), Erik Laube (Air Force Veteran), and Kristen Eldridge (military family member).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
none

FAQ

What is the current stock price of Maximus (MMS)?

The current stock price of Maximus (MMS) is $73.87 as of March 2, 2026.

What is the market cap of Maximus (MMS)?

The market cap of Maximus (MMS) is approximately 4.1B.

MMS Rankings

MMS Stock Data

4.12B
53.60M
Specialty Business Services
Services-business Services, Nec
Link
United States
MCLEAN

MMS RSS Feed